The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy

The main advantage of urinary biomarkers is their noninvasive character and the ability to detect multifocal prostate cancer (CaP). We have previously implemented a quadruplex assay of urinary markers into clinical practice (PCA3, AMACR, TRPM8 and MSMB with KLK3 normalization). In this study, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Huskova, Zlata, Knillova, Jana, Kolar, Zdenek, Vrbkova, Jana, Kral, Milan, Bouchal, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344460/
https://www.ncbi.nlm.nih.gov/pubmed/32630458
http://dx.doi.org/10.3390/biomedicines8060173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344460/
https://www.ncbi.nlm.nih.gov/pubmed/32630458
http://dx.doi.org/10.3390/biomedicines8060173

Ejemplares similares